A detailed history of California State Teachers Retirement System transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 4,141 shares of ZNTL stock, worth $12,837. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,141
Previous 52,462 92.11%
Holding current value
$12,837
Previous $214,000 92.99%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.9 - $4.57 $140,130 - $220,826
-48,321 Reduced 92.11%
4,141 $15,000
Q2 2024

Aug 14, 2024

BUY
$4.09 - $16.13 $8,454 - $33,340
2,067 Added 4.1%
52,462 $214,000
Q1 2024

May 15, 2024

SELL
$10.83 - $16.49 $34,894 - $53,130
-3,222 Reduced 6.01%
50,395 $794,000
Q4 2023

Feb 13, 2024

SELL
$9.84 - $20.13 $27,847 - $56,967
-2,830 Reduced 5.01%
53,617 $812,000
Q3 2023

Nov 14, 2023

SELL
$19.63 - $28.29 $186,367 - $268,585
-9,494 Reduced 14.4%
56,447 $1.13 Million
Q2 2023

Aug 21, 2023

BUY
$17.41 - $30.05 $145,860 - $251,758
8,378 Added 14.55%
65,941 $1.86 Million
Q1 2023

May 09, 2023

SELL
$16.14 - $24.94 $12,653 - $19,552
-784 Reduced 1.34%
57,563 $990,000
Q4 2022

Feb 14, 2023

BUY
$18.07 - $25.6 $10,805 - $15,308
598 Added 1.04%
58,347 $1.18 Million
Q3 2022

Nov 18, 2022

BUY
$20.23 - $31.73 $50,150 - $78,658
2,479 Added 4.49%
57,749 $1.25 Million
Q2 2022

Aug 15, 2022

BUY
$17.91 - $52.25 $365,149 - $1.07 Million
20,388 Added 58.45%
55,270 $1.55 Million
Q1 2022

May 16, 2022

SELL
$41.58 - $80.89 $168,523 - $327,847
-4,053 Reduced 10.41%
34,882 $1.61 Million
Q4 2021

Feb 15, 2022

BUY
$66.92 - $84.79 $177,271 - $224,608
2,649 Added 7.3%
38,935 $3.27 Million
Q3 2021

Nov 15, 2021

SELL
$46.83 - $73.5 $447,273 - $701,998
-9,551 Reduced 20.84%
36,286 $2.42 Million
Q2 2021

Aug 16, 2021

BUY
$37.41 - $62.25 $93,076 - $154,878
2,488 Added 5.74%
45,837 $2.44 Million
Q1 2021

May 18, 2021

SELL
$35.69 - $52.72 $4,675 - $6,906
-131 Reduced 0.3%
43,349 $1.88 Million
Q4 2020

Feb 16, 2021

BUY
$31.71 - $57.97 $825,601 - $1.51 Million
26,036 Added 149.25%
43,480 $2.26 Million
Q3 2020

Nov 17, 2020

BUY
$27.03 - $47.97 $50,194 - $89,080
1,857 Added 11.91%
17,444 $570,000
Q2 2020

Aug 17, 2020

BUY
$23.2 - $54.8 $361,618 - $854,167
15,587 New
15,587 $748,000

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $177M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.